These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9132763)

  • 1. [Sulpiride: an atypical neuroleptic with a wide spectrum of therapeutic claims].
    Wasieczko A; Wasieczko Z
    Psychiatr Pol; 1996; 30(6):1009-16. PubMed ID: 9132763
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atypical neuroleptics--a heterogenous group. Valuable option in acute psychoses].
    MMW Fortschr Med; 2002 May; Suppl 2():85. PubMed ID: 12070863
    [No Abstract]   [Full Text] [Related]  

  • 3. [Amisulpride--a neuroleptic agent for all phases of schizophrenia].
    Nervenarzt; 1999 Mar; 70(3 Suppl Amisulprid):1-8. PubMed ID: 10221135
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sulpiride: a neuroleptic agent of new generation with unique pharmacological qualities and rather wide range of clinical applications].
    Pawłowski L
    Psychiatr Pol; 1993; 27(2):199-205. PubMed ID: 8104350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A risk-benefit assessment of sulpiride in the treatment of schizophrenia.
    Mauri MC; Bravin S; Bitetto A; Rudelli R; Invernizzi G
    Drug Saf; 1996 May; 14(5):288-98. PubMed ID: 8800626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S19-26. PubMed ID: 12685918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.
    Dervaux A; Cazali J
    J Clin Psychopharmacol; 2007 Oct; 27(5):514-6. PubMed ID: 17873688
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose ziprasidone in treatment-resistant schizophrenia and affective spectrum disorders: a case series.
    Deutschman DA; Deutschman DH
    J Clin Psychopharmacol; 2007 Oct; 27(5):513-4. PubMed ID: 17873687
    [No Abstract]   [Full Text] [Related]  

  • 9. Sulpiride treatment of Cotard's syndrome in schizophrenia.
    Shiraishi H; Ito M; Hayashi H; Otani K
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):607-9. PubMed ID: 15093970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
    Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Solian: evaluation of 10 years' experimentation and clinical practice].
    Baldauf A; Metzger JY; Sichel JP
    Ann Med Psychol (Paris); 1988; 146(1-2):63-6. PubMed ID: 2901244
    [No Abstract]   [Full Text] [Related]  

  • 12. Amisulpride treatment of somatoform disorders: not just chronic fatigue.
    Goswami K; Saddichha S; Chaturvedi SK
    Am J Ther; 2014; 21(2):e48-9. PubMed ID: 23011165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy metabolism in the hypothalamus and plasma cortisol levels in patients with schizophrenia.
    Wik G
    Horm Metab Res; 1996 Apr; 28(4):205-6. PubMed ID: 8740199
    [No Abstract]   [Full Text] [Related]  

  • 14. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
    Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
    Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amisulpride: its role in the therapeutic management of the schizophrenic patient. Introduction.
    Darcourt G
    Acta Psychiatr Scand Suppl; 2000; 400():5-6. PubMed ID: 10823304
    [No Abstract]   [Full Text] [Related]  

  • 16. Two patients with recurring syndrome of inappropriate secretion of antidiuretic hormone on multiple atypical antipsychotics.
    Kahn D; Leung M; Kalivas K; Quanbeck C; Su A
    J Clin Psychopharmacol; 2009 Apr; 29(2):186-9. PubMed ID: 19512986
    [No Abstract]   [Full Text] [Related]  

  • 17. Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.
    Chen HK; Chen CK; Tzeng NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1615-6. PubMed ID: 18597910
    [No Abstract]   [Full Text] [Related]  

  • 18. Amisulpride: its role in the therapeutic management of the schizophrenia patient. Conclusions.
    Peuskens J
    Acta Psychiatr Scand Suppl; 2000; 400():28-9. PubMed ID: 10823309
    [No Abstract]   [Full Text] [Related]  

  • 19. Is amisulpride an 'atypical' atypical antipsychotic agent?
    Lecrubier Y
    Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S21-6. PubMed ID: 11252520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Compliance with treatment in schizophrenia and mood disorders].
    Sorvaniemi M; Kampman O
    Duodecim; 2000; 116(3):277-84. PubMed ID: 11764451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.